These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32472953)

  • 1. Paraneoplastic opsoclonus myoclonus syndrome associated with inflammatory myofibroblastic tumor in a pediatric patient.
    Gerstle K; Siddiqui A; Schulte JJ; Cohn SL
    Pediatr Blood Cancer; 2020 Aug; 67(8):e28218. PubMed ID: 32472953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab for treatment of opsoclonus-myoclonus syndrome in neuroblastoma.
    Burke MJ; Cohn SL
    Pediatr Blood Cancer; 2008 Mar; 50(3):679-80. PubMed ID: 16900484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment and revaccination of children with paraneoplastic opsoclonus-myoclonus-ataxia syndrome and neuroblastoma: The Memorial Sloan Kettering experience.
    Patel A; Fischer C; Lin YC; Basu EM; Kushner BH; De Braganca K; Khakoo Y
    Pediatr Blood Cancer; 2020 Aug; 67(8):e28319. PubMed ID: 32543116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An upfront immunomodulatory therapy protocol for pediatric opsoclonus-myoclonus syndrome.
    Wilbur C; Yea C; Licht C; Irwin MS; Yeh EA
    Pediatr Blood Cancer; 2019 Aug; 66(8):e27776. PubMed ID: 31033188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCR7 signaling in pediatric opsoclonus-myoclonus: upregulated serum CCL21 expression is steroid-responsive.
    Pranzatelli MR; Tate ED; McGee NR; Ransohoff RM
    Cytokine; 2013 Oct; 64(1):331-6. PubMed ID: 23764550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comprehensive treatment of neuroblastoma in children associated with opsoclonus-myoclonus-ataxia syndrome].
    Zhao W; Sun Q; Xie Y; Hua Y; Xiong H; Jia J; Lu X
    Zhonghua Er Ke Za Zhi; 2014 Jul; 52(7):540-3. PubMed ID: 25224062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Responsiveness to Reduced-Dose Rituximab in Corticotropin/Intravenous Immunoglobulin/Rituximab Combination Immunotherapy for Opsoclonus-Myoclonus Syndrome.
    Pranzatelli MR; Tate ED; McGee NR; MacArthur CA
    Pediatr Neurol; 2018 Aug; 85():71-75. PubMed ID: 30197220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Opsoclonus myoclonus syndrome secondary to abdominal neuroblastoma. Presentation of a pediatric clinical case].
    Urman G; Leivi M; Chamorro N; García B; Callea A; Grosman A
    Arch Argent Pediatr; 2019 Dec; 117(6):e651-e654. PubMed ID: 31758904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opsoclonus-myoclonus syndrome associated with pancreatic neuroendocrine tumor: a case report.
    Reinecke R; Reiländer A; Seiler A; Koch C; Voss M
    BMC Neurol; 2022 Dec; 22(1):507. PubMed ID: 36581905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic plasma exchange for a case of refractory opsoclonus myoclonus ataxia syndrome.
    Greensher JE; Louie J; Fish JD
    Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28926689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Detection and Treatment of Neuroblastic Tumor with Opsoclonus-Myoclonus Syndrome Improve Neurological Outcome: A Review of Five Cases at a Single Institution in Japan.
    Takama Y; Yoneda A; Nakamura T; Nakaoka T; Higashio A; Santo K; Kuki I; Kawawaki H; Tomiwa K; Hara J
    Eur J Pediatr Surg; 2016 Feb; 26(1):54-9. PubMed ID: 26409265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late cognitive and adaptive outcomes of patients with neuroblastoma-associated opsoclonus-myoclonus-ataxia-syndrome: A report from the Children's Oncology Group.
    Kumar P; Willard VW; Embry L; Naranjo A; LaBarre B; Matthay KK; de Alarcon PA
    Pediatr Blood Cancer; 2024 Jul; 71(7):e31039. PubMed ID: 38689540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Childhood opsoclonus-myoclonus syndrome: diagnosis and treatment.
    Blaes F; Dharmalingam B
    Expert Rev Neurother; 2016 Jun; 16(6):641-8. PubMed ID: 27095464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Opsoclonus-myoclonus syndrome associated with non-metastatic neuroblastoma. Long-term survival. Study of the French Society of Pediatric Oncologists].
    Plantaz D; Michon J; Valteau-Couanet D; Coze C; Chastagner P; Bergeron C; Nelken B; Martelli H; Peyroulet MC; Carpentier AF; Armari-Alla C; Pagnier A; Rubie H
    Arch Pediatr; 2000 Jun; 7(6):621-8. PubMed ID: 10911528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rituximab treatment for relapsed opsoclonus-myoclonus syndrome.
    Toyoshima D; Morisada N; Takami Y; Kidokoro H; Nishiyama M; Nakagawa T; Ninchoji T; Nozu K; Takeshima Y; Takada S; Nishio H; Iijima K
    Brain Dev; 2016 Mar; 38(3):346-9. PubMed ID: 26375512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opsoclonus-Myoclonus Syndrome: A New Era of Improved Prognosis?
    Galstyan A; Wilbur C; Selby K; Hukin J
    Pediatr Neurol; 2017 Jul; 72():65-69. PubMed ID: 28479124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethasone, Intravenous Immunoglobulin, and Rituximab Combination Immunotherapy for Pediatric Opsoclonus-Myoclonus Syndrome.
    Pranzatelli MR; Tate ED
    Pediatr Neurol; 2017 Aug; 73():48-56. PubMed ID: 28651977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival in paraneoplastic opsoclonus-myoclonus syndrome associated with small cell lung cancer.
    Hassan KA; Kalemkerian GP; Trobe JD
    J Neuroophthalmol; 2008 Mar; 28(1):27-30. PubMed ID: 18347455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nationwide survey of opsoclonus-myoclonus syndrome in Japanese children.
    Hasegawa S; Matsushige T; Kajimoto M; Inoue H; Momonaka H; Oka M; Ohga S; Ichiyama T;
    Brain Dev; 2015 Aug; 37(7):656-60. PubMed ID: 25454391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Increased Immunosuppression on Developmental Outcome of Opsoclonus Myoclonus Syndrome (OMS).
    Mitchell WG; Wooten AA; O'Neil SH; Rodriguez JG; Cruz RE; Wittern R
    J Child Neurol; 2015 Jul; 30(8):976-82. PubMed ID: 25342308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.